Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

NCT03727633 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Enrollement rythm low, funding body decision.

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Idarubicin and Lipiodol

Sponsor

University Hospital, Montpellier

Collaborators

[object Object]